117 related articles for article (PubMed ID: 18675787)
1. Alternative splicing generates a short BCL6 (BCL6S) isoform encoding a compact repressor.
Shen Y; Ge B; Ramachandrareddy H; McKeithan T; Chan WC
Biochem Biophys Res Commun; 2008 Oct; 375(2):190-3. PubMed ID: 18675787
[TBL] [Abstract][Full Text] [Related]
2. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
3. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
4. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
5. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.
Liu H; Ippolito GC; Wall JK; Niu T; Probst L; Lee BS; Pulford K; Banham AH; Stockwin L; Shaffer AL; Staudt LM; Das C; Dyer MJ; Tucker PW
Mol Cancer; 2006 May; 5():18. PubMed ID: 16704730
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.
Mascle X; Albagli O; Lemercier C
Biochem Biophys Res Commun; 2003 Jan; 300(2):391-6. PubMed ID: 12504096
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR.
Yoon J; Feng X; Kim YS; Shin DM; Hatzi K; Wang H; Morse HC
J Biol Chem; 2014 Dec; 289(49):34250-7. PubMed ID: 25331958
[TBL] [Abstract][Full Text] [Related]
8. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
[TBL] [Abstract][Full Text] [Related]
9. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
[TBL] [Abstract][Full Text] [Related]
10. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region.
Baron BW; Desai M; Baber LJ; Paras L; Zhang Q; Sadhu A; Duguay S; Nucifora G; McKeithan TW; Zeleznik-Le N
Genes Chromosomes Cancer; 1997 May; 19(1):14-21. PubMed ID: 9135990
[TBL] [Abstract][Full Text] [Related]
11. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
[TBL] [Abstract][Full Text] [Related]
12. Bcl6-dependent transcriptional repression by BAZF.
Takenaga M; Hatano M; Takamori M; Yamashita Y; Okada S; Kuroda Y; Tokuhisa T
Biochem Biophys Res Commun; 2003 Apr; 303(2):600-8. PubMed ID: 12659862
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
[TBL] [Abstract][Full Text] [Related]
14. Bcl6 is a transcriptional repressor for the IL-18 gene.
Takeda N; Arima M; Tsuruoka N; Okada S; Hatano M; Sakamoto A; Kohno Y; Tokuhisa T
J Immunol; 2003 Jul; 171(1):426-31. PubMed ID: 12817026
[TBL] [Abstract][Full Text] [Related]
15. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product.
Nakamura T; Yamazaki Y; Saiki Y; Moriyama M; Largaespada DA; Jenkins NA; Copeland NG
Mol Cell Biol; 2000 May; 20(9):3178-86. PubMed ID: 10757802
[TBL] [Abstract][Full Text] [Related]
16. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
17. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
18. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor.
Lemercier C; Brocard MP; Puvion-Dutilleul F; Kao HY; Albagli O; Khochbin S
J Biol Chem; 2002 Jun; 277(24):22045-52. PubMed ID: 11929873
[TBL] [Abstract][Full Text] [Related]
19. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
Pasqualucci L; Migliazza A; Basso K; Houldsworth J; Chaganti RS; Dalla-Favera R
Blood; 2003 Apr; 101(8):2914-23. PubMed ID: 12515714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]